Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Adenosine and Papaverine

supplement:

Adenosine

Research Papers that Mention the Interaction

Papaverine (5.32 microM) significantly enhanced the antiplatelet activity of adenosine (0.75 microM) in human whole blood, an effect that was not observed in PRP.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas  •  1992  |  View Paper
It was shown that dipyridamole and papaverine induce concentration-dependent inhibition of the absorption of [14C] adenosine by thymocytes.
Farmakologiia i toksikologiia  •  1986  |  View Paper
The difference in FFR between papaverine and 140 μg/kg/min dose of adenosine was significantly greater in the caffeine group than in the no-caffeine group (0.034 vs 0.004; P<.05).
The Journal of invasive cardiology  •  2014  |  View Paper
Papaverine , cilostazol, and rolipram also augmented both the magnitude and the duration of Isc following low dose stimulation of adenosine receptors with Ado (0.1-1.0 microM, P < 0.01).
American journal of respiratory cell and molecular biology  •  2003  |  View Paper
Coronary flow reserve was determined after intracoronary injection of 30 μg adenosine and 12 mg papaverine.
Heart  •  2002  |  View Paper
The effects of adenosine on intracellular calcium, as in the case of platelet aggregation, appear to be linked to adenylate cyclase, since they were prevented by the adenylate cyclase inhibitor 2',5'-dideoxyadenosine (1-mmol/L) and were potentiated by phospho-diesterase inhibition with papaverine (1 mumol/L).
American journal of hypertension  •  1992  |  View Paper
Adenosine is likely to affect intracellular Ca2+, by activating adenylate cyclase, since 2',5'-didesoxyadenosine (1 mM) prevents the effect of adenosine, by inhibiting the enzyme, whereas the phosphodiesterase inhibitor papaverine (1 microM) potentiates its effect.
Kardiologiia  •  1991  |  View Paper
There was a strong correlation between adenosine infusion and papaverine for both mean coronary flow velocity and coronary vasodilator reserve ratio (r2 = 0.871 and 0.325; SEE = 0.068 and 0.189, respectively; both p less than 0.0005).
Journal of the American College of Cardiology  •  1991  |  View Paper
The effects of adenosine on [Ca2+]i appear to be mediated through a rise in intracellular cAMP, because they were prevented by the adenylate cyclase inhibitor 2',5'-dideoxyadenosine (1 mM) and were potentiated by phosphodiesterase inhibition with papaverine (1 microM).
Molecular pharmacology  •  1990  |  View Paper
Papaverine markedly potentiated the increase in platelet cyclic [14C]AMP observed with all concentrations of adenosine , indicating that adenosine activates platelet adenylate cyclase.
Molecular pharmacology  •  1975  |  View Paper
Show More